GlassScriptPhysician profile
Nicholas M Brown
NPI 1639396757
$29,041.30
in general payments reported to CMS, 2019-2025
18 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,008 · 2020: $96.36 · 2021: $156 · 2022: $7,749 · 2023: $9,313 · 2024: $230 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $1,280 · Food and Beverage: $1,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,513.00 |
| Travel and Lodging | $1,279.74 |
| Food and Beverage | $1,239.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnilife Science, INC | $16,639.99 | 2022-2023 | Omnibotics 3.0 |
| Vertex Pharmaceuticals Incorporated | $10,398.63 | 2025 | |
| Medical Device Business Services, INC. | $804.13 | 2019 | |
| Tela Bio, INC. | $350.33 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $269.26 | 2019-2021 | |
| Ethicon US, LLC | $207.94 | 2019-2025 | Echelon Flex, Harmonic |
| Boston Scientific Corporation | $119.12 | 2024 | Spyglass Discover |
| Olympus America INC. | $51.04 | 2019-2023 | Oes Choledochofiberscope |
| Stryker Corporation | $48.64 | 2024 | Deaver |
| Davol INC. | $30.00 | 2022 | |
| Novo Nordisk INC | $29.74 | 2023 | Wegovy |
| Distalmotion US | $23.39 | 2025 | Dexter L6 Robot |
| Heron Therapeutics, INC. | $19.40 | 2022 | |
| Glaxosmithkline, LLC. | $18.51 | 2023 | Zejula, Jemperli |
| Hologic Sales and Service, LLC | $15.59 | 2023 | Coolseal Generator |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $13.23 | 2019 | |
| Endogastric Solutions, INC | $2.36 | 2024 | Esophyx |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.